Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05653336 · ClinicalTrials.gov registry record · NA
PerQseal® Clinical Study
A NA study of Percutaneous Large Hole Vascular Closure, sponsored by Vivasure Medical Limited.
- Active
- Registry status
- NA
- Development phase
- 149
- Enrollment target
- 18
- Study locations
NCT05653336 is a NA study of Percutaneous Large Hole Vascular Closure that is active but no longer recruiting, run by Vivasure Medical Limited. The registered enrollment target is 149 participants. The trial reports 18 study locations across 11 states.
The verdict
NCT05653336, a NA study of Percutaneous Large Hole Vascular Closure, is active but no longer recruiting, sponsored by Vivasure Medical Limited.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
- 18
- Study locations
Study Summary
The objective is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing percutaneous catheter-based interventional procedures.
Conditions Studied
Interventions
- DEVICE PerQseal® Closure Device System
Study Locations (18)
New York
- University of Buffalo - Buffalo
- Columbia University Medical Center/ NewYork Presbyterian Hospital - New York
- University of Rochester Medical Center - Rochester
- Stony Brook University Hospital - Stony Brook
- Montefiore Medical Center (multiple centers) - The Bronx
Pennsylvania
- UPMC Pinnacle Health - Mechanicsburg
- UPenn - Perelman Center for Advanced Medicine, - Philadelphia
- Lankenau Institute for Medical Research - Wynnewood
New Jersey
- Cooper University Hospital - Camden
- The Valley Hospital - Paramus
Arizona
- HonorHealth - Scottsdale
California
- Scripps - La Jolla
Maine
- Northern Light Eastern Maine Medical Center - Bangor
Ohio
- The Cleveland Clinic - Cleveland
Texas
- The Texas Heart Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2025-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05653336
The ClinicalTrials.gov registry entry for NCT05653336 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivasure Medical Limited, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Percutaneous Large Hole Vascular Closure appearing as the primary indexed condition, and to 1 intervention - of which PerQseal® Closure Device System is the first listed.
NCT05653336 reports 18 study locations spanning 11 distinct geographic areas - top geographies include New York, Pennsylvania, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05653336 about?
NCT05653336 is a clinical study titled "PerQseal® Clinical Study". The objective is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing percutaneous catheter-based interventional procedure...
What is the current status of trial NCT05653336?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 149 participants. The study started on 2023-03-30. Estimated completion is 2025-06.
What conditions does trial NCT05653336 study?
This clinical trial studies the following conditions: Percutaneous Large Hole Vascular Closure.
What interventions are being tested in trial NCT05653336?
The interventions under investigation include: PerQseal® Closure Device System (DEVICE).
Who is sponsoring clinical trial NCT05653336?
This trial is sponsored by Vivasure Medical Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05653336 being conducted?
This trial has 18 study locations across Arizona, California, Maine, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.